详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Efficacy of Single-Dose NEPA versus 3-Day Aprepitant Regimen for Prevention of CINV: A Phase 3 Lung Cancer Subset Analysis

文献详情

资源类型：

作者：

机构： [1]Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Shanghai, Peoples R China; [2]Sun Yat Sen Univ, Canc Ctr, Guangzhou, Guangdong, Peoples R China; [3]Prince Songkla Univ, Hat Yai, Thailand; [4]Helsinn Healthcare, Lugano, Switzerland; [5]Heidelberg Univ, Dept Med 5, Heidelberg, Germany; [6]Clin Genolier, Canc Ctr, Genolier, Switzerland

出处：

DOI：

ISSN：

关键词： CINV aprepitant NEPA

语种：

WOS：

中科院(CAS)分区：

出版当年[2017]版：

大类 | 2 区医学

小类 | 2 区肿瘤学 2 区呼吸系统

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学 1 区呼吸系统

第一作者：

第一作者机构： [1]Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Shanghai, Peoples R China;

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Quality of life (QOL) evaluation of patients in a phase 3 study comparing NEPA with an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) [2]Evaluation of daily breakthrough chemotherapy-induced nausea and vomiting (CINV) rates in a phase III study of NEPA versus an aprepitant (APR)/granisetron (GRAN) regimen [3]Prolonged administration of aprepitant improves cisplatin-based chemotherapy-induced nausea and vomiting [4]Phase 3 efficacy results of a single dose of NEPA, a fixed combination of netupitant and palonosetron, versus a 3-day regimen of aprepitant/granisetron (APR/GRAN) for prevention of chemotherapy-induced nausea and vomiting (CINV) in Chinese patients [5]Efficacy and safety of fosaprepitant in the prevention of nausea and vomiting following highly emetogenic chemotherapy in Chinese people: A randomized, double-blind, phase III study [6]Benefits and harms of NK1 R antagonists in pruritus: A systematic review and meta-analysis. [7]Efficacy and safety of fosaprepitant in the prevention of nausea and vomiting following highly emetogenic chemotherapy in Chinese people: A randomized, double-blind, phase III study [8]To Determine the Best Method to Prevent CINV Caused by TC Regimen in Patients With Gynecological Malignant Tumor. [9]风险模式导向下CINV评估对肠道肿瘤化疗患者生活质量的改善探讨 [10]8穴位止吐贴与NK-1受体拮抗剂对含铂双药化疗致患者CINV效价比的研究